NSE filing, NSE: IDEAFORGE. Summary written from the filing by ALFA Finder's alert engine.
ideaForge Technology Ltd: key numbers
- Share price
- ₹676.00
- Market cap
- ₹3,361 Cr
- Revenue (annual)
- ₹226.1 Cr
- Net profit (annual)
- ₹-17.03 Cr
- P/E (TTM)
- 854.9×Sector 52.0×
- Promoter holding
- 25.25%-3.71% QoQ
- FII holding
- 7.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ideaForge Technology Ltd
All →ideaForge Technology Merger & Restructuring
ideaForge's US subsidiary terminated its JV agreement with First Breach Inc. on October 23, 2026. Closing never occurred, so no shares were issued or capital contributed.
ideaForge Technology Board Meeting Date
IdeaForge Technology scheduled a Board meeting for November 2, 2026, to approve Q2 and H1 unaudited results. Trading window remains closed until 48 hours post-declaration.
ideaForge Technology Other Announcement
Ideaforge Technology Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes a category reclassification for Vipul Joshi.
ideaForge Technology Management Change
Mr. Nilesh Ranjan Jaywant has resigned as the Company Secretary, Compliance Officer, and KMP of ideaForge Technology Limited, effective December 25, 2026.
ideaForge Technology Employee Stock Options
ideaForge Technology allotted 7,467 equity shares to employees upon exercise of vested options under its 2018 ESOP scheme.
ideaForge Technology Debt & Borrowing: ₹151 Cr
ideaForge entered into a term loan agreement with Technology Development Board for ₹151 Crore to fund the development of its YETI autonomous aerial logistics project.
- Value
- ₹151.0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.